As a result, FOXD1 resists cellular senescence and facilitates HNSCC cell proliferation by affecting the expression of the p21/CDK2/Rb signaling pathway, suggesting that blockade of the FOXD1/p21/CDK2/Rb axis may be a potential treatment for HNSCC. The gene discussed is CDK2; the disease is head and neck squamous cell carcinoma.